Introduction: Non Syndromic Cleft lip/Palate is a common congenital anomaly with significant medical, psychological, social and economic ramifications. It is an example of complex genetic trait. There is sufficient evidence to hypothesize that disease locus for this condition can be identified by candidate genes. The purpose of this study was to test whether TGFB3 rs2300607 (IVSI+ 5321) gene variant was involved in the etiology of Non Syndromal Cleft lip/Palate. Materials and methods: Blood samples were collected with informed consent from 25 subjects having Non Syndromic Cleft lip/Palate and 25 controls .Genomic DNA was extracted from the blood samples, Polymerase Chain Reaction was performed (PCR) and digestion products were evaluated.
Introduction
The development of the head and face is one of the most complex and tightly controlled events during embryonic development. Disturbances during the period critical for the formation of face (7-10 weeks for humans) may lead to orofacial clefts. [1] Cleft lip and palate is one of the most common congenital malformations. Immediately after birth, individuals with cleft lip/palate have facial deformities, feeding problems and frequent middle ear infections, the treatment of which requires interventions from multiple disciplines. At the age of speech acquisition, speech therapy is often needed to correct problems resulting from muscular defects of the clefts. As the individual continues to grow, defects in tooth development and malocclusion require dental and sometimes surgical treatment. The increased duration of treatment from birth to adult hood is a burden for the patient, family & society. [2] Cleft Lip/Palate have a wide geographic distribution, with average birth prevalence in the world ranging from1/300 to 1/2500 births. Approximately two thirds of the cases are not accompanied by other anomalies and are called non syndromic (NS). [1] The etiology seems complex, but genetics plays a major role. Various candidate genes have been associated with Non Syndromal cleft lip/palate in different populations, but TGFB3 is strongly related in various populations on a consistent basis. TGFB3 is located on human chromosome 14q 24. It is expressed in the medial edge epithelium cells of palatal shelves and thought to contribute to palatal shelf elongation and fusions. Knockout mice studies with TGFB3 deletion have shown development of cleft palate. [3] The mutations and polymorphisms of TGFB3 have been shown to be diverse. One of variation for TGFB3 is rs2300607 (IVSI+ 5321). [4] The advents of molecular biology and advanced genetic techniques have allowed uncovering, characterizing and ultimately manipulating the genes that make up the genome. It is becoming clear that the molecular centre of embryogenic morphology resides at the level of gene, in particular within families of the gene that encode transcription factors capable of regulating downstream gene transcription. It is important for the clinicians to keep abreast with these developments. Therefore it is necessary to study about these genetic variations to elaborate our understanding of the genetic control in various craniofacial determinants. In the present study, the focus of interest is to study the relation of TGFB3 rs2300607 (IVSI+ 5321) gene variant to Non Syndromal Cleft Lip/Palate. This helps in understanding the etiology of Non syndromal Cleft Lip / Palate so as to predict its occurrence and also to target at the molecular level for correction of such problems in the future.
Materials & methods
The sample consisted of 25 subjects reporting to the cleft clinics of department of orthodontics and dentofacial orthopedics, D.A.P.M.R.V. Dental & Hospital, Bangalore, Karnataka, India and 25 unrelated controls. Written informed consents were obtained from all subjects .The study was carried out after approval from institutional ethical committee and guidelines from Helinsiki declaration were followed. Subjects were grouped into two groups based on the presence of Non Syndromal Cleft Lip/Palate. Group A: Twenty five subjects with Non Syndromal Cleft Lip/ Palate, Group B: Twenty five control subjects. A thorough clinical examination was done. Patients having Cleft lip/palate associated with any History of developmental disabilities, including learning disabilities and attention deficits, hearing impairment, and speech deficits or abnormalities were excluded from the study. [5, 6] Blood samples (1.5ml) were obtained from both Subjects and controls. Genomic DNA was extracted from the blood of the subjects by using ethanol, chloroform treatment. Once the isolated genomic DNA precipitate is obtained, it was used as a template for the polymerase chain reaction (PCR) test. The TGFB3 gene was amplified by PCR. The primers used in this study were procured from New England Laboratories, USA having the following base pair sequence. GGTTTAAACATTGTTTTGGC. [3] The PCR product (404 [bp]) thus obtained was run on 1.5% agarose gel containing ethidium bromide to assess the initial amplified PCR products. The amplified PCR products were digested with the specific restriction enzymes Apo1 at 37°C. The method adopted for PCR was Restriction Fragment Length Polymorphism (RFLP).The digested PCR products were separated into channels on a 1.5% agarose gel containing ethidium bromide in an electrophoretic chamber. A U.V.transilluminator was used to see the specific bands of base pairs of the digested PCR products [4] . 
Results
The initial PCR product of the TGFB3 gene was obtained for the fifty subjects .The size of this PCR product was 404bp. (Fig.1) . After obtaining the initial PCR products of TGFB3 gene (404 bp) from groups A and B, samples were then subjected to digestion with the specific restriction enzyme Apo1. After digestion, the 404 bp products were completely digested with two restriction sites and three specific bands of 214,140 and 50 bp in 15 subjects of Group A whereas all subjects in Group B showed incomplete/no digestion. (Figure 2 ) So the presence of variant was shown only in 15 subjects of Group A and none in group B.
Discussion
Identification of the genes involved in the development of the human craniofacial region can serve as a first step towards developing a better understanding of diagnosis, treatment and preventions of developmental anomalies of this regions. [7] The genetic background of Non Syndromal cleft lip/palate is complex and most causes remain yet to be identified.
The process of palatal fusion is also controlled by interactive signaling from the mesenchyme to the epithelium which is mediated by growth factors and extracellular matrix (ECM) proteins. One of the key components in this process is TGFΒ3 expression which coordinates palatogenesis. (Britto et al ) [8] This gene(TGFB3) determines extracellular matrix protein accumulation by stimulating extracellular matrix protein neosynthesis thereby inhibiting many enzymes which are responsible for extracellular matrix protein degradation . ( Blavier et al.) [9] This reduced activity of TGFΒ3 due to genetic variation may increase the risk for oral clefts. Consistent with this hypothesis, TGFΒ3 knockout mice studies have shown a developmental defect of secondary palate. (Proetzal et al,) [10] In this study the presence of TGFB3 gene variant in a sample of 50 subjects was assessed. A significant association was seen in Group A Subjects with TGFB3 gene variant as compared to controls. These findings suggest that these gene variants have a role in the etiology of non syndromal cleft lip/palate in our population).This is in accordance with the studies done by Andrew C. Lidral etal in South American population [11] , J.Suazo etal in Chilean population [12] . However this study is contrary to a study done by Andrew C. Lidral etal. in Philippines population [13] which may be due to genetic differences in that population.
In Group B it was observed that there was no association with the gene variant. In this study 40% of the cases having non syndromal cleft lip/palate did not show any of these gene variants .This may suggest the possibility of involvement of other genes as non syndromal cleft lip/palate is of polygentic nature and studies suggest that other genes like TGFB3, RARA, BCLX3, TGFαA, MTHR, PVLRI [1, 14] are involved in the etiology of non syndromal cleft lip/palate.
Conclusion
This study indicates that there is strong association between the presence of TGFB3 rs2300607 (IVSI+ 5321)gene variant with the incidence of non syndromal cleft lip and palate and it may act as a genetic marker for non syndromal cleft lip and palate in this population.
Studies about such genetic markers of non syndromic cleft lip and palate will help us to predict and target at the molecular level in treating such problems. A major challenge is not only a complete cataloguing of all such genes involved in the etiology of non syndromal cleft lip palate but identification of their polygenetic nature to have a thorough understanding of the craniofacial development. The future challenge is to bring this new knowledge from the "level of PCR sequencer into the clinical realms".
